William John Scheessele - 13 Dec 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role: Chief Commercial Officer
Signature: /s/ William John Scheessele by Dale A. Sander as Attorney-in-Fact
Issuer symbol: HUMA
Transactions as of: 13 Dec 2022
Net transactions value: +$15,450
Form type: 4
Filing time: 15 Dec 2022, 18:53:54 UTC
Previous filing: 12 Dec 2022
Next filing: 12 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HUMA	Common Stock	Purchase	$15,450	+5,000	+48%	$3.09	15,525	13 Dec 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.